• Who we are

    Olink Proteomics is dedicated to innovation, quality, rigor and transparency, providing outstanding solutions and support for human protein biomarker discovery.

    Global relationships, local labs and proudly Swedish

    In a few short years, Olink has grown rapidly from a small, Sweden-based company offering assay for a few hundred proteins, to a NASDAQ-listed organization with a strong global presence, a broad portfolio of flexible protein biomarker solutions and library of high quality, thoroughly validated assays that cover ~3000 proteins.

    A little history

    Olink Proteomics was forged from a history of proteomics innovation and development that took place here in Uppsala. Read on to find out how this innovation influenced the creation of PEA and how Olink continues to honor this spirit today.

    Olink today and tomorrow

    The promise of proteomics: Together with our customers, Olink is accelerating proteomics to better understand human biology and develop future healthcare. We are on a journey to explore the low-abundance plasma proteome to uncover actionable insights that can drive the development of precision medicine.

    More about us

    Use the links below to meet our esteemed leadership team, learn more about our commitment to integrity and compliance, access materials from our media press kit, or read our press releases.

    Visit the Olink investors’ website to see our leadership team of company officers

     

    Access relevant images and other materials pertaining to Olink from our media kit.

    Olink is committed to a policy of strict integrity and compliance around personal data protection.

    Visit the Olink investors’ website to see all of our official press releases.

    2947

    Biomarker assays

    ~881 million

    Protein data points generated

    886

    Publications listed on website

    Contact us!